We suggest to use Aptose Biosciences fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Aptose Biosciences is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We are able to interpolate and collect twenty-nine available fundamental indicators for Aptose Biosciences, which can be compared to its peers. The stock experiences a very speculative upward sentiment. Check odds of Aptose Biosciences to be traded at C$0.285 in 90 days. Key indicators impacting Aptose Biosciences' financial strength include:
Understanding current and past Aptose Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aptose Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Aptose Biosciences' assets may result in an increase in income on the income statement.
Aptose Biosciences competes with Medicenna Therapeutics, and Oncolytics Biotech. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Toronto, Canada. APTOSE BIOSCIENCES operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. It employs 22 people.
Foreign Associate
USA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
You should never invest in Aptose Biosciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Aptose Stock, because this is throwing your money away. Analyzing the key information contained in Aptose Biosciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Aptose Biosciences Key Financial Ratios
Aptose Biosciences' financial ratios allow both analysts and investors to convert raw data from Aptose Biosciences' financial statements into concise, actionable information that can be used to evaluate the performance of Aptose Biosciences over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Aptose Biosciences's current stock value. Our valuation model uses many indicators to compare Aptose Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aptose Biosciences competition to find correlations between indicators driving Aptose Biosciences's intrinsic value. More Info.
Aptose Biosciences is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . At this time, Aptose Biosciences' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Aptose Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aptose Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.
Aptose Biosciences Systematic Risk
Aptose Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aptose Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Aptose Biosciences correlated with the market. If Beta is less than 0 Aptose Biosciences generally moves in the opposite direction as compared to the market. If Aptose Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aptose Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aptose Biosciences is generally in the same direction as the market. If Beta > 1 Aptose Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
Aptose Biosciences Total Assets Over Time
Today, most investors in Aptose Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aptose Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aptose Biosciences growth as a starting point in their analysis.
Aptose Biosciences January 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aptose Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aptose Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aptose Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Aptose Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aptose Biosciences's daily price indicators and compare them against related drivers.
When determining whether Aptose Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptose Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptose Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptose Biosciences Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.